Skip to main content
. 2017 Sep;21(5):321–329. doi: 10.18869/acadpub.ibj.21.5.321

Fig. 2.

Fig. 2

Forest plots presenting the odds ratio and 95% confidence intervals for the evaluated biomarker. Odds of developing (A) gastritis or (B) gastric cancer, in reference to H. pylori-positive asymptomatic controls. Double positive, HP-NAP seropositive/C-590T carriers; double negative HP-NAP seronegative/IL-4 -590 CC. All calculations were adjusted for age, gender, and ethnicity.